Healthcare News - An Overview
Novo CEO pressed by Senate to cut costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the business would think about new talks with insurers with regards to the checklist charges of Wegovy and copyright should they pledge to keep the medicines on their formularies.The offer has to be finished by Sept. t